Drawing for HELSINN HELSINN ADVANCED SYNTHESIS WHERE PASSION, RELIABILITY AND QUALITY MEET

USPTO serial 79264628

HELSINN HELSINN ADVANCED SYNTHESIS WHERE PASSION, RELIABILITY AND QUALITY MEET

Reviewed by CopyMark Law Group

Reg. 6144147Status 700Renewal
Filing date
Status date
Registration date
Sep 8, 2020
Examiner
JOINER, KATINA JACKSON
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with HELSINN HELSINN ADVANCED SYNTHESIS WHERE PASSION, RELIABILITY AND QUALITY MEET?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*

Plus Government fees of $1,275

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Amanda Laura Nye

Amanda Laura Nye Amanda Nye Law Offices6 Davis Drive, Suite EBelvedere Tiburon, CA 94920UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005A full line of pharmaceuticals in the field of supportive cancer care; pharmaceutical preparations, namely, anti-inflammatory drugs, antiemetic drugs, drugs for the treatment of cancer, carcinoma, leukemia, lymphoma, melanoma, anti-tumor drugs, anti-emetic, anti-tumor and anticancer pharmaceutical preparations for the treatment of oncological diseases and the side effects of treatment; drugs for use in case of ulcerative and inflammatory conditions, anti-anxiety drugs, anti-migraine drugs, cognition enhancing drugs, drugs for the prevention and treatment of gastroenterological, hepatologic, nephrologic and cardiovascular disorders of any origin; drugs for internal cleansing purposes, bowel cleansers and evacuants for medical and pharmaceuticals purposes, veterinary vaccines and sanitary preparations for medical use; dietetic foods adapted for medical use, food for babies; medical and surgical plasters, materials for dressings in the nature of bandages; materials for stopping teeth, dental wax; disinfectants for sanitary and hygiene purposes; preparations for destroying vermin; fungicides, herbicidesACTIVE—
040Custom manufacture of pharmaceutical products per customer order and in accordance with customer requirementsACTIVE—
042Research and development of pharmaceutical products; scientific and industrial research for the development of medicines and active ingredients; chemistry services, namely, consultancy in the field of chemical and pharmaceutical technology; engineering services, including expertise in the field of chemical and pharmaceutical technologyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 20, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Sep 8, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jul 19, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 15, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 28, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Dec 28, 2020FIMPFINAL DISPOSITION PROCESSED—
Dec 8, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 8, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 23, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 23, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 19, 2020GPNXNOTIFICATION PROCESSED BY IB—
Jun 3, 2020OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jun 3, 2020OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jun 3, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 21, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 23, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 23, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 22, 2020ALIEASSIGNED TO LIE—
Apr 18, 2020NREVNOTICE OF REVIVAL - MAILED—
Apr 17, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 17, 2020PETGPETITION TO REVIVE-GRANTED—
Apr 17, 2020PROATEAS PETITION TO REVIVE RECEIVED—
Mar 24, 2020MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Mar 23, 2020ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Sep 28, 2019RFNTREFUSAL PROCESSED BY IB—
Sep 10, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 10, 2019RFRRREFUSAL PROCESSED BY MPU—
Aug 27, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 26, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 20, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 16, 2019DOCKASSIGNED TO EXAMINER—
Aug 16, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 8, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance